Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(32.89) per share which beat the analyst consensus estimate of $(50.50) by 34.87 percent. This is a 95.57 percent increase over losses of $(742.50) per share from the same period last year. The company reported quarterly sales of $697.000 thousand which beat the analyst consensus estimate of $110.000 thousand by 533.64 percent. This is a 1.27K percent increase over sales of $51.000 thousand the same period last year.